|
Type 2 diabetes
Citations 151-160 of 286 total displayed.
|
Past content
(since Dec 2000):
|
- Editorial Commentary
New Guidelines on Diet and Blood Pressure
- Thomas G. Pickering
Hypertension published January 9, 2006, doi:10.1161/01.HYP.0000202417.57909.26
[Abstract]
- Scientific Contributions
Glucagon Receptor-Mediated Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in Rat Mesangial Cells. Role of Protein Kinase A and Phospholipase C
- Xiao C. Li, Oscar A. Carretero, Yuan Shao, and Jia L. Zhuo
Hypertension published January 3, 2006, doi:10.1161/01.HYP.0000197946.81754.0a
[Abstract]
- Scientific Contributions
Complex Relationship Between Blood Pressure and Mortality in Type 2 Diabetic Patients. A Follow-Up of the Botnia Study
- Mats Rönnback, Bo Isomaa, Johan Fagerudd, Carol Forsblom, Per-Henrik Groop, Tiinamaija Tuomi, Leif Groop for the Botnia Study Group
Hypertension published December 27, 2005, doi:10.1161/01.HYP.0000199667.30253.b7
[Abstract]
- Scientific Contributions
Risk Factors for Arterial Hypertension in Adults With Initial Optimal Blood Pressure. The Strong Heart Study
- Giovanni de Simone, Richard B. Devereux, Marcello Chinali, Mary J. Roman, Lyle G. Best, Thomas K. Welty, Elisa T. Lee, Barbara V. Howard for the Strong Heart Study Investigators
Hypertension published December 27, 2005, doi:10.1161/01.HYP.0000199103.40105.b5
[Abstract]
- Scientific Contributions
Regulation of Peroxisome Proliferator-Activated Receptor  Activity by Losartan Metabolites
- Michael Schupp, Lucas D. Lee, Nikolaj Frost, Sumaira Umbreen, Boris Schmidt, Thomas Unger, and Ulrich Kintscher
Hypertension published December 19, 2005, doi:10.1161/01.HYP.0000196946.79674.8b
[Abstract]
- Brief Reviews
Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor- Activators
- Seung Hwan Han, Michael J. Quon, and Kwang Kon Koh
Hypertension 2005;46:1086-1092; published online before print as doi:10.1161/01.HYP.0000187900.36455.4c
[Abstract]
[Full text]
- Original Articles
Body Fat Distribution, Liver Enzymes, and Risk of Hypertension: Evidence From the Western New York Study
- Saverio Stranges, Maurizio Trevisan, Joan M. Dorn, Jacek Dmochowski, and Richard P. Donahue
Hypertension 2005;46:1186-1193; published online before print as doi:10.1161/01.HYP.0000185688.81320.4d
[Abstract]
[Full text]
- Brief Reviews
Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor- Activators
- Seung Hwan Han, Michael J. Quon, and Kwang Kon Koh
Hypertension published October 17, 2005, doi:10.1161/01.HYP.0000187900.36455.4c
[Abstract]
- Scientific Contributions
Body Fat Distribution, Liver Enzymes, and Risk of Hypertension. Evidence From the Western New York Study
- Saverio Stranges, Maurizio Trevisan, Joan M. Dorn, Jacek Dmochowski, and Richard P. Donahue
Hypertension published October 3, 2005, doi:10.1161/01.HYP.0000185688.81320.4d
[Abstract]
- Editorial Commentaries
Overweight and Increased Cardiovascular Mortality: No French Paradox
- Frank B. Hu
Hypertension 2005;46:645-646; published online before print as doi:10.1161/01.HYP.0000184229.64767.a1
[Full text]
|
|
